Karriereverlauf von Rafi Kazandjian
Ehemalige bekannte Positionen von Rafi Kazandjian
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | 22.05.2014 | - |
| Vorstandsvorsitzender | 22.05.2014 | 12.12.2017 | |
| Vorsitzender | 22.05.2014 | - | |
| Präsident | 22.05.2014 | 12.12.2017 | |
Immutep SAS
 Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Direktor/Vorstandsmitglied | - | 18.11.2015 |
Statistik
International
| Frankreich | 3 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sektoral
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Immutep SAS
Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Health Technology |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Commercial Services |
- Börse
- Insiders
- Rafi Kazandjian
- Erfahrung
